DOI 10.1080/07853890.2024.2445780
Research advances in the diagnosis and treatment of MASLD/MASH.
Аннотация
Background
The global increase in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and its progression to Metabolic Dysfunction-Associated Steatohepatitis (MASH) pose significant public health challenges.
Objective
To review key research advancements in the diagnosis and treatment of MASLD/MASH over the past two decades.
Methods
This article synthesizes recent findings on diagnostic and therapeutic strategies for MASLD/MASH, focusing on non-invasive diagnostic tools and emerging pharmacological treatments.
Results
Non-invasive diagnostic techniques, including high-resolution CT, MRI, FIB-4 index, and FAST score, have enhanced early detection and diagnostic accuracy. Treatment strategies encompass pharmaceuticals such as THR-β agonists, FXR agonists, PPAR agonists, GLP-1 receptor agonists, and SGLT2 inhibitors, alongside lifestyle interventions like dietary changes, weight management, and exercise. Surgical options, including gastric bypass and liver transplantation, are effective, particularly for obese and advanced MASH patients. However, challenges remain in standardizing treatment protocols, validating long-term efficacy, and addressing patient-specific factors.
Conclusion
MASLD/MASH treatment has advanced significantly with new diagnostic tools and therapies. Future research should focus on personalized approaches, long-term treatment outcomes, and multidisciplinary collaboration to improve patient care and treatment efficacy.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.